Document and Entity Information [Abstract] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Document Quarterly Report Document Period End Date Document Transition Report Securities Act File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag CONDENSED CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Line Items] Statement Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Total cash and cash equivalents Deferred Income Taxes and Other Tax Receivable, Current Tax credits Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Total prepaid expenses and other current assets Assets, Current Total current assets Assets, Noncurrent [Abstract] Noncurrent assets: Property, Plant and Equipment, Net Property and equipment, net Property and equipment, net Capitalized Computer Software, Net Internal-use software, net Internal-use software, net Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Restricted Cash, Noncurrent Restricted cash Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer and noncurrent assets classified as other. Deposits And Other Assets, Noncurrent Long-term deposits and other noncurrent assets Assets, Noncurrent Total noncurrent assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' equity Liabilities [Abstract] Liabilities: Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Operating Lease, Liability, Current Operating lease liabilities - current Other Liabilities, Current Other current liabilities Total other current liabilities Long-Term Debt, Current Maturities Loans - current Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Noncurrent liabilities: Liability, Defined Benefit Pension Plan, Noncurrent Defined benefit pension plan Operating Lease, Liability, Noncurrent Operating lease liabilities - noncurrent Long-Term Debt, Excluding Current Maturities Loans - noncurrent Liabilities, Noncurrent Total noncurrent liabilities Liabilities Total liabilities Equity, Attributable to Parent [Abstract] Stockholders' equity Preferred Stock, Value, Issued Preferred stock, $0.0001 par value; 10,000,000 shares authorized; nil shares issued and outstanding as of March 31, 2026 and December 31, 2025 Common Stock, Value, Issued Common stock, $0.0001 par value: 100,000,000 shares authorized; 42,488,578 and 42,073,807 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively Additional Paid in Capital Additional paid-in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Retained Earnings (Accumulated Deficit) Accumulated deficit The current period income or loss. Income Loss For The Period Loss of the period Equity, Attributable to Parent Balance, end of period Balance, beginning of period Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized Authorized capital, Preferred stock (in shares) Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common stock par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Authorized capital, Common stock (in shares) Common Stock, Shares, Issued Common stock, shares, issued Common stock issued (in shares) Common Stock, Shares, Outstanding Common stock, shares, outstanding Common stock outstanding (in shares) CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income (expense): Interest Income (Expense), Nonoperating Interest income, net Gain (Loss), Foreign Currency Transaction, before Tax Foreign exchange loss, net Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income tax Income Tax Expense (Benefit) Income tax Income tax Net loss Net loss Net Loss per Common Share Net loss per shares: Earnings Per Share, Basic Net loss per share attributable to common stockholders - basic Earnings Per Share, Diluted Net loss per share attributable to common stockholders - diluted Weighted Average Number of Shares Outstanding, Basic Weighted average common stock - basic Weighted Average Number of Shares Outstanding, Diluted Weighted average common stock - diluted CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent Changes in defined benefit pension plan obligation, net of tax Changes in defined benefit pension plan obligation (Note 10) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign currency translation Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other comprehensive income, net of tax Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional Paid-in Capital AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) Retained Earnings [Member] Accumulated Deficit Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents the information pertaining to Placement Agent Warrants. Agent Warrants Agent warrants (a) Shares, Outstanding Balance, end of period (in shares) Balance, beginning of period (in shares) Equity impact of the value of new stock issued during the period in at the market offerings. Stock Issued During Period, Value, New Issues, At the Market Offering Issuance of shares in at-the-market (ATM) offering (Note 13) Stock Issued During Period, Shares, New Issues, At-the-Market-Offerings. Stock Issued During Period, Shares, New Issues, At the Market Offerings Issuance of shares in at-the-market (ATM) offering (Note 13) (shares) Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Stock-based compensation (Note 14) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Stock-based compensation (Note 14) (in shares) Value of stock issued as a result of exercise of warrants. Stock Issued During Period, Value, Warrants Exercised Exercise of warrants (Note 13) Number of shares issued as a result of exercise of warrants. Stock Issued During Period, Shares, Warrants Exercised Exercise of warrants (Note 13) (shares) Shares issued on exercise of warrants Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures RSU vesting (Note 14) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures RSU vesting (Note 14) (shares) CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation, Depletion and Amortization Depreciation and amortization Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Other Noncash Income (Expense) Other non-cash items Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Other Noncurrent Assets Long term deposit and other noncurrent assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and other current liabilities Increase (Decrease) in Obligation, Pension Benefits Defined benefit pension plan Increase (Decrease) in Deferred Liabilities Deferred grant income Increase (Decrease) in Operating Capital Total changes in operating assets and liabilities Net Cash Provided by (Used in) Operating Activities Cash used in operating activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flow from financing activities: Proceeds from Issuance of Common Stock in At-the-market Offerings Proceeds from Issuance of Common Stock in At The Market Offerings Net proceeds from issuance of shares in 2024 ATM Program (Note 13) Proceeds from Warrant Exercises Net proceeds from the exercise of warrants (Note 13) Net proceeds from warrant exercises Repayments of Short-Term Debt Payments of current portion of long-term debt (Note 11) Net Cash Provided by (Used in) Financing Activities Cash provided by financing activities Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Effect of exchange rate changes Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash, cash equivalents and restricted cash at end of period Cash, cash equivalents and restricted cash at beginning of period Nature of the Business and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Nature of the Business and Basis of Presentation Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Information pertaining to research grants. Research Grants The entire disclosure of information pertaining to research grants. Research Grants Disclosure [Text Block] Research Grants Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents Disclosure [Text Block] Cash, Cash Equivalents and Restricted Cash Tax Credits, Prepaid Expenses and Other Current Assets The entire disclosure for Prepaid expenses and other current assets. Prepaid Expenses and Other Current Assets [Text Block] Tax Credits, Prepaid Expenses and Other Current Assets Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] Property and Equipment, Net Operating Leases Lessee, Operating Leases [Text Block] Operating Leases Accounts Payable. Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accounts Payable Other Current Liabilities Other Liabilities Disclosure [Text Block] Other Current Liabilities Pension and Other Benefit Programs Retirement Benefits [Text Block] Pension and Other Benefit Programs Loans Debt Disclosure [Text Block] Loans Fair Value Measurement Fair Value Disclosures [Text Block] Fair Value Measurement No definition available. Common, Preferred Stock and Warrants The entire disclosure for equity and warrants. Stockholder's Equity and Warrants Disclosure [Text Block] Common, Preferred Stock and Warrants Equity Incentive Plan Compensation Related Costs, General [Text Block] Equity Incentive Plan Earnings Per Share [Text Block] Net Loss per Common Share Related Parties Related Party Transactions Disclosure [Text Block] Related Parties Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Subsequent Events Subsequent Events [Text Block] Subsequent Events Segment Reporting, Policy [Policy Text Block] Segment Information Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Disclosure of policy for going concern assessment. Description of policy for going concern assessment [Policy Text Block] Going Concern Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Transactions Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentrations of Credit Risk Deferred Charges, Policy [Policy Text Block] Issuance Costs Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment Research, Development, and Computer Software, Policy [Policy Text Block] Capitalized Software Development Costs Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Impairment of Long-lived Assets Intangible Assets, Finite-Lived, Policy [Policy Text Block] Patents Lessee, Leases [Policy Text Block] Leases Disclosure of accounting policy for accounts payable. Accounts Payable Policy [Text Block] Accounts Payable Disclosure of accounting policy for payables for social securities. Payables for Social Securities Policy [Text Block] Payables for Social Security Charges Disclosure of accounting policy for accrued expenses. Accrued Expenses Policy [Policy Text Block] Accrued Expenses Pension and Other Postretirement Plans, Policy [Policy Text Block] Pension Obligations Compensation Related Costs, Policy [Policy Text Block] Stock-based Compensation Disclosure of accounting policy for warrants. Warrants [Policy Text Block] Warrants Disclosure of accounting policy research grants. Research Grants Policy [Policy Text Block] Research Grants Research and Development Expense, Policy [Policy Text Block] Research and Development Expenses Selling, General and Administrative Expenses, Policy [Policy Text Block] General and Administrative Expenses Income Tax, Policy [Policy Text Block] Income Taxes Fair Value Measurement, Policy [Policy Text Block] Fair Value Measurement Comprehensive Income, Policy [Policy Text Block] Comprehensive Income / (Loss) Earnings Per Share, Policy [Policy Text Block] Net Loss per Share New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Tabular disclosure for depreciation rates on property plant and equipment. Depreciation Rates On Property Plant And Equipment [Table Text Block] Schedule of depreciation rates Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of internal-use software, net Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of classification of accumulated other comprehensive loss as reflected in the consolidated balance sheets Restrictions on Cash and Cash Equivalents [Table Text Block] Schedule of cash, cash equivalents and restricted cash Tabular disclosure for Prepaid expenses and other current assets. Schedule of Prepaid Expenses and Other Current Assets [Table Text Block] Schedule of tax credits, prepaid expenses and other current assets Property, Plant and Equipment [Table Text Block] Schedule of Property and equipment Lease, Cost [Table Text Block] Schedule of operating lease expenses Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of future minimum lease payments Other Current Liabilities [Table Text Block] Schedule of other current liabilities Schedule of Defined Benefit Plans Disclosures [Table Text Block] Schedule of pension obligations Schedule of Maturities of Long-Term Debt [Table Text Block] Schedule of future loan payments Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block] Schedule of assets measured at fair value Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule of fair value of the warrants estimated using the Black-Scholes option pricing model Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Company's issued and outstanding warrants Tabular disclosure of warrants activity. Schedule Of Warrants Activity [Table Text Block] Schedule of Company's warrants activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of the Company's stock option activity Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of assumptions to determine grant-date fair value of stock options granted during the period Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block] Schedule of unvested restricted stock units Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Schedule of stock-based compensation expense recognized for stock options granted to employees and non-employees Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of potentially dilutive common stock excluded from the computation of diluted net loss per share attributable to common stockholders Schedule of Revenues from External Customers and Long-Lived Assets [Table] Revenues from External Customers and Long-Lived Assets [Line Items] Long-lived assets by geographic location Number of Operating Segments Number of operating segments Stock, Class of Stock [Table] Class of Stock [Line Items] Summary of Significant Accounting Policies Common, Preferred Stock and Warrants Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Accumulated currency translation adjustments Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Unrealized foreign exchange gain (loss) Property, Plant and Equipment [Table] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Domain] Represents the information pertaining to Equipment & Furniture. Equipment & Furniture Equipment & furniture Office Equipment [Member] Electronic office equipment Represents the information pertaining to Laboratory instruments. Laboratory instruments Laboratory equipment Property, Plant and Equipment [Line Items] Summary of Significant Accounting Policies Property and Equipment, Net Percentage of depreciation on property plant and equipment. Property Plant and Equipment, Depreciation Rates Depreciation rates (as a percent) Asset Impairment Charges Impairments of long-lived assets Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Expected dividend yield The reduction of research and development expenses through expenses reimbursed Reduction of research and development expenses through expenses reimbursed Reduction of research and development expenses through expenses reimbursed Intangible Asset, Finite-Lived [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Computer Software, Intangible Asset [Member] Capitalized Software Finite-Lived Intangible Assets [Line Items] Capitalized Software Development Costs Capitalized Computer Software, Gross Internal-use software Capitalized Computer Software, Accumulated Amortization Less: accumulated amortization Finite-Lived Intangible Asset, Useful Life Capitalized software development costs useful life Capitalized Computer Software, Amortization Amortization expense, capitalized software development costs Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Defined Benefit Pension Obligation Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Foreign Currency Translation Accumulated Other Comprehensive Income (Loss) [Line Items] Summary of Significant Accounting Policies Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Other comprehensive income (loss) before reclassifications Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Amounts reclassified from accumulated other comprehensive loss Disaggregation of Revenue [Table] Legal Entity [Axis] All Entities [Member] Represents the information pertaining to a consortium with GT Gain Therapeutics SA, Institute for Research in Biomedicine, Newcells Biotech and the University of Helsinki Consortium with GT Gain Therapeutics SA, Institute for Research in Biomedicine, Newcells Biotech and the University of Helsinki [Member] Consortium with GT Gain Therapeutics SA, Institute for Research in Biomedicine, Newcells Biotech and the University of Helsinki Counterparty Name [Axis] Counterparty Name [Domain] Represents the information pertaining to Eurostars and Innosuisse Eurostars and Innosuisse [Member] Eurostars and Innosuisse Represents the information pertaining to Innosuisse Innosuisse [Member] Innosuisse Represents the information pertaining to Australian government. Australian Government [Member] Australian Government Disaggregation of Revenue [Line Items] Research Grants Amount of research grant awarded. Amount of Research Grant Awarded Amount of research grant awarded The cash outflow for the repayment of grants awarded. Repayment Of Grants Unused portion of granted awards repaid Amount of research grant awarded, amended amount. Amount of Research Grant Awarded, Amended Amount Amount of research grant awarded, amended amount Grants Receivable Research grants receivables Cash and Cash Equivalent [Table] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Cash [Member] Cash Money Market Funds [Member] Money market funds Money market Cash and Cash Equivalents [Line Items] Cash, Cash Equivalents and Restricted Cash Restricted Cash Restricted cash Other Prepaid Expense, Current Prepaid and deferred expenses Amount of consideration paid in advance for research and development that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Prepaid Research And Development Prepaid research and development service agreements Prepaid Insurance Prepaid directors and officers (D&O) insurance costs Grants Receivable, Current Research and development grant receivable, net Computer Equipment [Member] Computer Furniture and Fixtures [Member] Furniture and fixtures Leasehold Improvements [Member] Leasehold improvements Property, Plant and Equipment, Gross Total property and equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: accumulated depreciation Property, Plant and Equipment, Disposals Disposals Depreciation Depreciation expense Lessee, Lease, Description [Table] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Research and Development Expense [Member] Research and development General and Administrative Expense [Member] General and administrative Lessee, Lease, Description [Line Items] Operating Leases Operating Lease, Cost Total operating lease costs Short-Term Lease, Cost Short term lease cost Lessee, Operating Lease, Liability, to be Paid, Next Rolling 12 Months 2026 Lessee, Operating Lease, Liability, to be Paid, Rolling Year Two 2027 Lessee, Operating Lease, Liability, to be Paid, Rolling Year Three 2028 Lessee, Operating Lease, Liability, to be Paid, Rolling Year Four 2029 Lessee, Operating Lease, Liability, to be Paid, Rolling Year Five 2030 Lessee, Operating Lease, Liability, to be Paid Total future minimum lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less amount representing interest or imputed interest Operating Lease, Liability Present value of lease liabilities Loss Contingencies [Table] Loss Contingencies [Line Items] Other Current Liabilities and Deferred Income Accrual for Taxes Other than Income Taxes, Current Payable for social security and withholding taxes Accrued Employee Benefits, Current Accrued payroll Carrying value as of the balance sheet date of obligations incurred through that date and payable for the research and development. Accrued Research and Development, Current Accrued research and development Accrued Professional Fees, Current Accrued professional fees Other Accrued Liabilities, Current Accrued other Accrued Income Taxes, Current Tax provision Defined Benefit Plan [Table] Retirement Plan Type [Axis] Retirement Plan Type [Domain] Pension Plan [Member] Pension Plan Defined Benefit Plan Disclosure [Line Items] Component of net periodic pension costs: Pension and Other Benefit Programs Defined Benefit Plan, Service Cost Service cost Defined Benefit Plan, Interest Cost Interest cost Defined Benefit Plan, Expected Return (Loss) on Plan Assets Expected return on plan assets Defined Benefit Plan, Amortization of Gain (Loss) Amortization of losses Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Amortization of prior service credit Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Total Defined Benefit Plan, Plan Assets, Contributions by Employer Employer contributions Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year Expected contributions Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument, Name [Domain] August 2020 CHF loan August 2020 CHF loan Debt Instrument [Line Items] Loans Debt Instrument, Face Amount Loan amount Debt Instrument, Term Term of loan Debt Instrument, Interest Rate, Stated Percentage Interest rate (as a percent) Debt Issuance Costs, Net Deferred issuance costs Long-Term Debt Total Long-Term Debt, Maturities, Repayments of Principal in Next Rolling 12 Months 2026 Long-Term Debt, Maturities, Repayments of Principal in Rolling Year Two 2027 Long-Term Debt, Maturities, Repayments of Principal in Rolling Year Three 2028 Long-Term Debt, Maturities, Repayments of Principal in Rolling Year Four 2029 Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Level 1 Asset Class [Axis] Asset Class [Domain] Cash and Cash Equivalents [Member] Total cash equivalents Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value Measurement Assets, Fair Value Disclosure Assets, Fair Value Disclosure Sale of Stock [Axis] Sale of Stock [Domain] Represents information pertaining to the At The Market Offering Program 2024. At The Market Offering Program 2024 [Member] At The Market Offering Program 2024 Represents information pertaining to Public Offering July 2025. Public Offering July 2025 [Member] Public offering July 2025 Over-Allotment Option [Member] Underwriters' option Represents the information pertaining to Public Warrants. Public Warrants Public Warrants Represents information pertaining to investor warrants. Investor Warrants [Member] Investor Warrants 2025 Investor Warrants Represents information pertaining to 2025 underwriter warrants. Underwriter Warrants 2025 [Member] 2025 Underwriter Warrants Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum Weighted Average [Member] Weighted average Stock Issued During Period, Shares, New Issues Shares issued Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of shares called by warrants or rights Number of warrants in each unit offered in an offering. Number Of Warrants In Each Unit Under Offering Number of warrants per unit Number of common stock in each unit offered in an offering. Number Of Common Stock In Each Unit Under Offering Number of common shares per unit Offering Price Per Unit Offering Price Per Unit Offering price per unit The effective price per share. Effective Price Per Share Effective price per share The effective price per warrant. Effective Price Per Warrant Effective price per warrant Class of Warrant or Right, Exercise Price of Warrants or Rights Weighted Average Exercise Price, outstanding at the end of period Weighted Average Exercise Price, outstanding at the beginning of period Exercise price of warrant or right Weighted Average Exercise Price (in dollars per share) Proceeds from Issuance or Sale of Equity Gross proceeds Payments of Stock Issuance Costs Offering expenses The amount of cash inflow associated with the issuance of common stock and warrants, after deduction of issuance expenses. Proceeds From Issuance of Shares and Warrants in Public Offering Net proceeds The number of warrants exercised during the period. Warrants Exercised Warrants Exercised (in shares) Warrants Exercised (in shares) Class of Warrant or Right, Number of Additional Securities Called by Warrants Received if Options are Exercised. Class of Warrant or Right, Number of Additional Securities Called by Warrants Received if Options are Exercised Number of additional shares called by warrants received if options are exercised Warrants and Rights Outstanding, Term Expected term (years) Warrants and Rights, Commencement of Exercise Term. Warrants and Rights, Commencement of Exercise Term Warrants, commencement of exercise term Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Sales commissions and other offering expenses Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock being a offering expense. Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs, Offering Expense Other offering expenses Aggregate offering price in at the market offering Aggregate offering price in at the market offering Aggregate offering price in at the market offering Percentage of sales commission payable Percentage of sales commission payable Percentage of sales commission payable Average selling price per share of equity issued. Average Selling Price Per Share Average selling price Proceeds from Issuance of Common Stock Aggregate gross proceeds The cash inflow from the additional capital contribution to the entity, after deduction of issuance costs. Net Proceeds from Issuance of Common Stock Net proceeds from issuance of common stock Class of Warrant or Right [Table] Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input, Price Volatility [Member] Volatility Measurement Input, Risk Free Interest Rate [Member] Risk-free interest rate Class of Warrant or Right [Line Items] Common, Preferred Stock and Warrants Warrants, Market Price Per Warrant at Grant Date Warrants, Market Price Per Warrant at Grant Date Market price at grant date Warrants and Rights Outstanding, Measurement Input Warrants, measurement input The grant date fair value of warrants granted during period. Warrants, grant date fair value Grant date fair value per share Information by expiry date of warrants. Class of Warrant or Right Expiration Date [Axis] Information by expiry date of warrants. Class of Warrant or Right Expiration Date [Domain] Represents information relating to warrants expiring on November,2028. Warrants expiring on November 24, 2028 [Member] Warrants expiring on November 24,2028 Represents information relating to warrants expiring on June 17, 2029. Warrants expiring on June 17, 2029 [Member] Warrants expiring on June 17, 2029 Represents information relating to warrants expiring on July 17, 2030. Warrants Expiring On July 17, 2030 [Member] Warrants expiring on July 17, 2030 Warrant [Member] Warrants to purchase common stock Class of Warrant or Right, Outstanding Warrants outstanding, ending (in shares) Warrants Outstanding, beginning (in shares) Warrants Outstanding (in shares) The number of warrants exercisable. Warrants Exercisable Number Warrants Exercisable (in shares) The weighted average exercise price of warrants exercised during the period. Warrants, Exercises in Period, Weighted Average Exercise Price Weighted Average Exercise Price, warrants exercised during the period The number of warrants withheld and canceled during the period. Warrants Withheld And Canceled Warrants withheld and canceled Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Plan Name [Axis] Plan Name [Domain] Represents the information pertaining to the 2021 Inducement Equity Incentive Plan Twenty-twenty One Inducement Equity Incentive Plan [Member] 2021 Inducement Equity Incentive Plan Represents the information pertaining to incentive plans 2020 and 2022 Incentive plans 2020 and 2022 [Member] Incentive plans 2020 and 2022 Options to purchase common stock Restricted Stock Units (RSUs) [Member] RSUs RSUs Vesting [Axis] Vesting [Domain] Share-Based Payment Arrangement, Tranche One [Member] Share-based payment arrangement, tranche one Share-Based Payment Arrangement, Tranche Two [Member] Share-based payment arrangement, tranche two Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Equity Incentive Plan Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Maximum number of shares reserved for issuance Annual increase in shares authorized for issuance under share-based payment arrangement, percentage of common stock issued and outstanding at the beginning of the year Annual increase in shares authorized for issuance under share-based payment arrangement, percentage of common stock issued and outstanding at beginning of year Annual increase in shares authorized for issue under plan, as percentage of common stock issued and outstanding at beginning of year Number of shares issuable more than ten years after original plan was authorized Number of shares issuable more than ten years after original plan was authorized Number of shares issuable more than ten years after original plan was authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Stock options grant period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Stock options exercise period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Percentage of stock options to vest Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized compensation cost related to non-vested stock options and RSUs Total unrecognized expense remaining Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unrecognized compensation cost, recognition period Years unrecognized expense expected to be recognized over Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Options outstanding as at end of period (in shares) Outstanding as at beginning of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Options cancelled/forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Weighted Average Fair Value Per Share, options outstanding at end of period Weighted Average Fair Value Per Share, options outstanding at beginning of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted Average Fair Value Per Share, options granted Grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value Weighted Average Fair Value Per Share, options cancelled/forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price Per Share, Options outstanding as at end of period Weighted Average Exercise Price Per Share, Outstanding as at beginning of period Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted Average Exercise Price Per Share, Options granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted Average Exercise Price Per Share, Options cancelled/forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Numbers of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Ending balance Beginning balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period RSUs vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period RSUs cancelled/forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted Average Grant Date Fair Value per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Ending balance, Weighted Average Grant Date Fair Value Beginning balance, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value RSUs vested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value RSUs cancelled/forfeited, Weighted Average Grant Date Fair Value Share-Based Payment Arrangement, Expense Total stock-based compensation Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net Loss per Common Share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive securities (in shares) Related Party Transaction [Table] Related Party Transaction [Axis] Related Party Transaction [Domain] Represents the information pertaining to license agreement with Minoryx Therapeutics SL. License agreement Minoryx Therapeutics SL Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Domain] Related Party [Member] Related Party Represents the information pertaining to Minoryx Therapeutics SL Minoryx Therapeutics SL [Member] Minoryx Therapeutics SL Related Party Transaction [Line Items] Related Parties Percentage of revenues that would infringe at least one composition of matter claim. Related Party Transaction, Percentage of Net Revenues, Based on One Composition of Matter Claim Percentage of net revenue based on one composition matter Percentage of revenues that would infringe at least one method of matter claim. Related Party Transaction, Percentage of Net Revenues, Based on One Method of Claim Percentage of net revenue based on one method of claim Accounts Receivable, after Allowance for Credit Loss Receivables Accounts Payable Payables Revenues Revenues Operating Costs and Expenses Expenses Other Commitments [Table] Other Commitments [Axis] Other Commitments [Domain] Research and Development Arrangement [Member] Research Agreements Litigation Case [Axis] Litigation Case [Domain] Represents the information pertaining to the litigation case concerning the termination of the former CEO's employment. Litigation case, termination of former CEO's employment [Member] Litigation case, termination of former CEO's employment Other Commitments [Line Items] Commitments and Contingencies Contractual Obligation Commitments Loss Contingency Accrual Accrual for litigation Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent event Subsequent Event [Line Items] Subsequent Events